Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(2)
Clinical Outcome
Immune Reconstitution
Subscribe
Academic
Publications
Partially Matched, Nonmyeloablative Allogeneic Transplantation: Clinical Outcomes and Immune Reconstitution
Partially Matched, Nonmyeloablative Allogeneic Transplantation: Clinical Outcomes and Immune Reconstitution,10.1200/JCO.2006.07.0953,Journal of Clinic
Edit
Partially Matched, Nonmyeloablative Allogeneic Transplantation: Clinical Outcomes and Immune Reconstitution
(
Citations: 54
)
BibTex
|
RIS
|
RefWorks
Download
D. A. Rizzieri
,
L. P. Koh
,
G. D. Long
,
C. Gasparetto
,
K. M. Sullivan
,
M. Horwitz
,
J. Chute
,
C. Smith
,
J. Z. Gong
,
A. Lagoo
,
D. Niedzwiecki
,
J. M. Dowell
http://academic.research.microsoft.com/io.ashx?type=5&id=30784610&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Journal of Clinical Oncology - J CLIN ONCOL
, vol. 25, no. 6, pp. 690-697, 2007
DOI:
10.1200/JCO.2006.07.0953
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.jco.org
)
Citation Context
(14)
...On the other hand, because CD52 is not so highly expressed on NK and gamma-delta T cells compared with CD4?/CD8? T cells, the use of alemtuzumab may merit an anti-tumor benefit by retaining these cells to a higher degree [
11
]...
...49 patients with hematologic malignancies or marrow failure [
11
] (Table 1). Mycophenolate mofetil with or without cyclosporine was used for GVHD prophylaxis...
...In our analysis of 49 patients who received a haploidentical graft after reduced-intensity conditioning including 100 mg alemtuzumab, CMV reactivation and disease occurred in 86 and 14%, respectively, and the main causes of death were infection (22% of the total causes of death) and disease progression (49%) [
11
]...
...Unmodified donor T cell infusions have been used to induce conversion from mixed to complete chimerism, augment graft-versus-tumor effect, and improve immune reconstitution [
11
, 18, 19, 28, 29]...
Junya Kanda
,
et al.
Alemtuzumab for the prevention and treatment of graft-versus-host dise...
...29,
...
K K Ballen
,
et al.
The great debate: haploidentical or cord blood transplant
...22,
...
S O Ciurea
,
et al.
Reduced-intensity conditioning using fludarabine, melphalan and thiote...
...36,
...
A Safdar
,
et al.
Infections in non-myeloablative hematopoietic stem cell transplantatio...
...17,
...
S R Yoon
,
et al.
Generation of donor natural killer cells from CD34+ progenitor cells a...
Sort by:
Citations
(54)
Alemtuzumab for the prevention and treatment of graft-versus-host disease
Junya Kanda
,
Richard D. Lopez
,
David A. Rizzieri
Journal:
International Journal of Hematology - INT J HEMATOL
, vol. 93, no. 5, pp. 586-593, 2011
The great debate: haploidentical or cord blood transplant
K K Ballen
,
T R Spitzer
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 46, no. 3, pp. 323-329, 2011
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
(
Citations: 6
)
S O Ciurea
,
R Saliba
,
G Rondon
,
S Pesoa
,
P Cano
,
M Fernandez-Vina
,
S Qureshi
,
L L Worth
,
J McMannis
,
P Kebriaei
,
R B Jones
,
M Korbling
http://academic.research.microsoft.com/io.ashx?type=5&id=28520073&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 45, no. 3, pp. 429-436, 2010
Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning
(
Citations: 9
)
Frédéric Baron
,
Chantal Lechanteur
,
Evelyne Willems
,
France Bruck
,
Etienne Baudoux
,
Laurence Seidel
,
Jean-François Vanbellinghen
,
Kaoutar Hafraoui
,
Marie Lejeune
,
André Gothot
,
Georges Fillet
,
Yves Beguin
Journal:
Biology of Blood and Marrow Transplantation - BIOL BLOOD MARROW TRANSPLANT
, vol. 16, no. 6, pp. 838-847, 2010
HLA-Haploidentical Stem Cell Transplantation for Hematologic Malignancies
(
Citations: 4
)
Ephraim J. Fuchs
,
Xiao-jun Huang
,
Jeffrey S. Miller
Journal:
Biology of Blood and Marrow Transplantation - BIOL BLOOD MARROW TRANSPLANT
, vol. 16, no. 1, pp. S57-S63, 2010